Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 7/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7051341 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL1128341 | 0.98 | ALDH1A1 (0.48) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL1468764 | 0.93 | TSHR (0.43) | ALDH1A1TSHREPHX1RECQL | |
| SCHEMBL29315079 | 0.93 | EPHX1 (0.46) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL25906823 | 0.93 | EPHX1 (0.46) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL3454834 | 0.93 | EPHX1 (0.46) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL3454627 | 0.93 | EPHX1 (0.46) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL19418922 | 0.90 | ALDH1A1 (0.56) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL15430605 | 0.90 | ALDH1A1 (0.56) | ALDH1A1TSHREPHX1ACHENAAA | |
| SCHEMBL18287422 | 0.90 | ALDH1A1 (0.56) | ALDH1A1TSHREPHX1ACHENAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1304325-A1 | 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-23 | — | — | EP | disclosed |